Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | NPY2R | P49146 | 8/20 | 0.64 |
| ▸ | NPY4R | P50391 | 8/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.64 |
| ▸ | NPY1R | P25929 | 6/20 | 0.64 |
| ▸ | CALCR | P30988 | 4/20 | 0.63 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.63 |
| ▸ | TFPI | P10646 | 3/20 | 0.63 |
| ▸ | GLP1R | P43220 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182683 | 0.93 | NPY2R (0.71) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL30432066 | 0.93 | EP300 (0.67) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL31182678 | 0.91 | NPY2R (0.63) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL30658303 | 0.90 | NPY2R (0.68) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL30335483 | 0.90 | NPY2R (0.64) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL29562124 | 0.90 | NPY2R (0.67) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL31000870 | 0.89 | MAPK8 (0.67) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL30432021 | 0.89 | NPY2R (0.68) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL22263594 | 0.89 | NPY2R (0.67) | EP300HIF1ANPY2RNPY4RNPY5R | |
| SCHEMBL30906574 | 0.89 | NPY2R (0.66) | EP300HIF1ANPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022147897-A1 | USE OF RXFP1/3 INHIBITOR IN PREPARATION OF MEDICATION FOR PREVENTING OR TREATING ADOLESCENT IDIOPATHIC SCOLIOSIS DISEASE | 张莉 | 2022-07-14 | — | — | WO | disclosed |